SEC Form SC 13G filed by Quotient Limited
$QTNT
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Health Care
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
12/3/2021 | $4.00 → $3.50 | Neutral | Goldman Sachs |
8/6/2021 | $5.00 → $4.50 | Neutral | Goldman Sachs |